FilingReader Intelligence
Kehua Bio-Engineering subsidiary secures new medical device registrations
July 28, 2025 at 01:02 PM UTC•By FilingReader AI
Shanghai Kehua Bio-Engineering's subsidiary, Suzhou Tianlong Bio-Technology, has obtained new medical device registration certificates for diagnostic kits.
The registrations include kits for detecting respiratory syncytial virus and adenovirus using fluorescent PCR method, valid until July 16, 2030. Another registration covers Hepatitis C Virus Antibody Quality Control product using chemiluminescence method, valid until July 23, 2030.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Shanghai Kehua Bio-Engineering publishes news
Free account required • Unsubscribe anytime